Experts say that for 2008 the price of steel will remain unpredictable due to a supply crunch and cost increases. For the first two weeks of February, the price of hot rolled steel increased 6%, and Lehman Brothers analysts have predicted that worldwide steel prices will increase 25% in 2008. Unlike the US steel panic […]
A $1 billion project to decode the DNA of 100,000 people will be undertaken by Harvard University scientist George Church with the backing of Google and OrbiMed Advisors. Dr. Church’s project will focus on tying each subject’s DNA to their health history in order to create a database with which to develop new medicines. The […]
According to Semiconductor Equipment and Materials International (SEMI), the semiconductor industry experienced its second best year ever in 2007,with worldwide sales for semiconductor manufacturing equipment of $42.77 billion, a 6% increase from 2006. Experts believe this increase is due to both the growth of the 300 mm ramp and intensive memory investments. The statistics are […]
PricewaterhouseCoopers reports that mergers and acquisitions (M&A) activity within the energy industry is expected to be weaker this year. In 2007, the total value of deals increased from $291.1 billion to $292.2 billion. Most of this increase took place in the downstream and oil services sectors. The total value of deals in the oil field […]
The United States Council for Aid Education’s Voluntary Support of Education (VSE) survey, which tracks data from 1,023 institutions, reports that charitable contributions to US colleges and universities increased 63% in 2007 to $29.75 billion. Twenty institutions raised $7.66 billion in total for 2007, making up 25.8% of all contributions to colleges and universities. The […]
Chemical firms will increase their capital spending 8.6% to nearly $8.8 billion, according to an early February survey of 17 companies by Chemical & Engineering News (C&EN). For 2007, C&EN reports that the actual capital spending of the 18 companies surveyed increased by 13.2% to $8.1 billion. Survey results from 14 companies indicate R&D spending […]
President Bush’s proposed budget, released February 4, for fiscal year 2009 calls for a 3.3% increase in the federal R&D investment to $145.4 billion. Federal support of basic and applied R&D would drop 0.5% to $57.1 billion, with a 3.1% increase in basic research spending to $29.3 billion and a 4.0% decrease in applied research […]
The FDA approved 17 new molecular entities (NMEs) and two biological license applications in 2007, the lowest number of new approvals since 2002. Nine of the 19 approvals were the subject of priority review status, which is given to a drug for which few available treatments exist. Four of the new approvals were for oncology […]
Battelle and R&D Magazine estimate that federal support of R&D in 2008 will increase 2.46% to $102 billion. Industry support will increase 3.61% to $235.7 billion, 3.58% to $2.6 billion, and 3.23% to $1.4 billion with respect to the industrial, academic and nonprofit sectors. Academic R&D spending is predicted to rise 3.70% to $13 billion. […]
A European assessment of drug research practices published in Regulatory Toxicology and Pharmacology has found that acute toxicity tests on animals are unnecessary. In Europe, slightly fewer than 500,000 rats and mice are used annually for toxicity testing. The report estimates that approximately 15,000 animals a year could be spared if the acute toxicity test […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
